Vegan diet reduces insulin use by 28% in type 1 diabetes

A low-fat vegan diet has shown promise in helping people with type 1 diabetes cut their daily insulin needs by nearly 30%, according to new research. The study, published in BMC Nutrition, found that participants on this plant-based plan also saved on insulin costs without restricting calories or carbohydrates. In contrast, those following a portion-controlled diet saw no significant changes.

The research, a secondary analysis of a 2024 clinical trial conducted by the Physicians Committee for Responsible Medicine, involved comparing a low-fat vegan diet to a portion-controlled approach in individuals with type 1 diabetes. Over 12 weeks, participants on the vegan diet reduced their total daily insulin dose by 28%, equivalent to 12.1 units per day. This group also experienced a 27% drop in daily insulin expenses, amounting to $1.08 less per day, while the comparison group showed no notable reductions.

Type 1 diabetes requires insulin because the body does not produce enough of the hormone, which helps move glucose into cells for energy. Some patients develop insulin resistance, where cells do not respond well to insulin, often exacerbated by dietary fat. The study suggests the vegan diet improved insulin sensitivity, allowing better glucose management.

Beyond insulin use, the original 2024 trial reported further benefits for the vegan group, including an average weight loss of 11 pounds, better glycemic control, lower cholesterol levels, and improved kidney function. These outcomes occurred without calorie or carbohydrate restrictions.

The findings are particularly relevant amid rising insulin costs in the United States. National spending on insulin tripled over the past decade to $22.3 billion in 2022, with prices increasing 24% from 2017 to 2022 after inflation adjustments.

"As insulin prices continue to rise, people with type 1 diabetes should consider a low-fat vegan diet, which can help improve their insulin sensitivity and reduce the amount of insulin they need, potentially saving them hundreds of dollars a year," said Hana Kahleova, MD, PhD, lead author and director of clinical research at the Physicians Committee for Responsible Medicine.

The study was published in BMC Nutrition in 2025, with full details available via DOI: 10.1186/s40795-025-01175-2.

Verwandte Artikel

Split-image illustration contrasting healthy (whole grains, plants, unsaturated fats) vs. unhealthy (refined carbs, animal fats) low-carb and low-fat diets, highlighting heart disease risk reduction from food quality per recent study.
Bild generiert von KI

Study links heart benefits of low-carb and low-fat diets to food quality, not macronutrient cuts

Von KI berichtet Bild generiert von KI Fakten geprüft

A long-running analysis of nearly 200,000 U.S. health professionals found that both low-carbohydrate and low-fat eating patterns were associated with lower coronary heart disease risk when they emphasized high-quality foods such as whole grains, plant-based sources, and unsaturated fats. Versions of these diets built around refined carbohydrates and animal-based fats and proteins were associated with higher risk, according to a study published in the Journal of the American College of Cardiology (JACC).

A randomized, placebo-controlled trial led by Australia’s Garvan Institute of Medical Research found that metformin, a long-used and low-cost drug for type 2 diabetes, did not improve clamp-measured insulin resistance in adults with type 1 diabetes but was associated with roughly 12% lower insulin requirements while blood sugar measures remained broadly unchanged.

Von KI berichtet

New research published in Nature Medicine reveals that people with prediabetes can normalize blood sugar levels without losing weight. About one in four participants in lifestyle programs achieved this remission, offering protection against diabetes similar to weight loss methods. The key factors involve fat distribution and certain hormones.

A clinical trial from the University of Bonn shows that consuming mostly oatmeal for two days can reduce harmful LDL cholesterol by 10 percent in people with metabolic syndrome. The benefits, including changes in gut bacteria, persisted for six weeks. Participants also experienced modest weight loss and lower blood pressure.

Von KI berichtet

A new Cochrane review of 22 clinical trials shows that intermittent fasting does not lead to greater weight loss than standard diet advice for overweight or obese adults. The analysis, involving nearly 2,000 participants, challenges the popularity of fasting methods amid rising global obesity rates. Researchers emphasize the need for more long-term studies and personalized approaches.

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen